A. LeTiran et al. / Bioorg. Med. Chem. 9 (2001) 2693–2708
2707
1994, 37, 4567. (i) Choi, D.; Stables, J. P.; Kohn, H. J. Med.
Chem. 1996, 39, 1907.
21. The crystallographic data from 4 has been deposited with
Cambridge Crystallographic Data Centre, 12Union Road,
Cambridge CB21EZ, UK.
22. Anderson, G. W.; Zimmerman, J. E.; Callahan, F. M. J.
Am. Chem. Soc. 1967, 87, 5012.
23. (a) For examples of N-tBoc deprotection with HCl, see:
Stahl, G. L.; Walter, R.; Smith, C. W. J. Org. Chem. 1978, 43,
2285. (b) Greene, T. W.; Wuts, P. G. M. Protective Groups in
Organic Synthesis, 2nd ed; John Wiley and Sons: New York,
1991, and references cited therein.
24. Olsen, R. K. J. Org. Chem. 1970, 35, 1912.
25. Battersby, A. R.; Breuer, S. W.; Garratt, S. J. Chem. Soc.
(C) 1968, 2467.
2. (a) Roberts, G. C. Curr. Opin. Biotechnol. 1999, 10, 42. (b)
Stochman, B. J. Prog. NMR Spectrosc. 1998, 33, 109.
3. (a) Boger, D. L.; Labroli, M. A.; Marsilje, T. H.; Jin, Q.;
Hedrick, M. P.; Baker, S. J.; Shim, J. H.; Benkovic, S. J.
Bioorg. Med. Chem. 2000, 1075. (b) Hruby, V. J. Life Sci.
1982, 31, 189. (c) Liskamp, R. M. J. Recl. Trav. Chim. Pays-
Bas 1994, 113, 1.
4. (a) Amblard, M.; Daffix, I.; Berge, G.; Calmes, M.; Dodey,
P.; Pruneau, D.; Pacquet, J.-L.; Luccarini, J.-M.; Belichard,
P.; Martinez, J. J. Med. Chem. 1999, 42, 4193. (b) Holladay,
M. W.; Bennett, M. J.; Tufano, M. D.; Lin, C. W.; Asin,
K. E.; Witte, D. G.; Miller, T. R.; Bianchi, B. R.; Nikkel,
A. L.; Bednarz, L.; Nadzan, A. M. J. Med. Chem. 1992, 35, 2919.
5. (a) Pettitt, M. B. J. Phys. Chem. 1988, 3994. (b) Lau, F. L.;
Pettitt, B. M. Biopolymers 1987, 26, 1817. (c) Pettitt, B. M.;
Karplus, M. Chem. Phys. Lett. 1985, 121, 194.
26. Andurkar, S. V.; Stables, J. P.; Kohn, H. Tetrahedron:
Asymmetry 1998, 9, 3841.
27. (a) Dorman, D. E.; Boyvey, F. A. J. Org. Chem. 1973, 38,
2379. (b) Beausoleil, E.; Lubell, W. D. J. Am. Chem. Soc.
1996, 118, 12902.
6. Chipot, C.; Pohorille, A. J. Phys. Chem. B 1998, 102, 281.
7. Toniolo, C. Int. J. Pept. Protein Res. 1990, 35, 287.
8. Creighton, T. E. Proteins Structure and Molecular Proper-
ties, 2nd ed; W. H. Freeman: New York, 1992.
9. For examples of peptide with cis conformer favored, see:
(a) Sukumaran, D. K.; Prorok, M.; Lawrence, D. S. J. Am.
Chem. Soc. 1991, 113, 706. (b) Magaard, V. W.; Sanchez,
R. M.; Bean, J. W.; Moore, M. L. Tetrahedron Lett. 1993, 34,
381. (c) Samanen, J.; Zuber, G.; Bean, J.; Eggleston, D.;
Romoff, T.; Kopple, K.; Saunders, M.; Regoli, D. Int. J.
Peptide Res. 1990, 35, 501. (d) Lenman, M. M.; Ingham, S. L.;
Gani, D. Chem. Commun. 1996, 85.
10. (a) Zabrocki, J.; Smith, G. D.; Dunbar, J. B., Jr.; Iijima,
H.; Marshall, G. R. J. Am. Chem. Soc. 1988, 110, 5875. (b)
Toniolo, C. Biopolymers 1989, 28, 247. (c) Yu, K.-L.; Johnson,
R. L. J. Org. Chem. 1987, 52, 2051. (d) Boteju, L. W.; Hruby,
V. J. Tetrahedron Lett. 1993, 34, 1757. (e) Beusen, D. D.;
Zabrocki, J.; Slomczynska, U.; Head, R. D.; Kao, J. L.-F.;
Marshall, G. R. Biopolymers 1995, 36, 181.
11. (a) Freidinger, R. M.; Veber, D. F.; Perlow, D. S.; Brooks,
J. R.; Saperstein, R. Science 1980, 210, 656. (b) Freidinger,
R. M.; Perlow, D. S.; Veber, D. F. J. Org. Chem. 1982, 47,
104. (c) Freidinger, R. M. J. Org. Chem. 1985, 50, 3631. (d)
Freidinger, R. M.; Veber, D. F.; Hirschmann, R.; Paege, L. M.
Int. J. Pept. Protein Res. 1980, 16, 464.
12. (a) Yanagisawa, H.; Ishihara, S.; Ando, A.; Kanazaki, T.;
Miyamoto, S.; Koike, H.; Iijima, Y.; Oizumi, K.; Matsushita,
Y.; Hata, T. J. Med. Chem. 1988, 31, 422. (b) Thorsett, E. D.;
Harris, E. E.; Aster, S. D.; Peterson, E. R.; Snyder, J. P.;
Springer, J. P.; Hirshfield, J.; Tristram, E. W.; Patchett, A. A.;
Ulm, E. H.; Vassil, T. C. J. Med. Chem. 1986, 29, 251.
13. Delgrado, W. F. Adv. Protein Chem. 1988, 39, 51.
14. (a) Di Maio, J.; Belleau, B. J. Chem. Soc. Perkin Trans 1
1989, 1687. (b) Pohlmann, A.; Schanen, V.; Guillaume, D.;
Quirion, J.-C.; Husson, H.-P. J. Org. Chem. 1997, 62, 1016.
15. Valle, G.; Crisma, M.; Toniolo, C.; Yu, K.-L.; Johnson,
R. L. Int. J. Peptide Protein Res. 1989, 33, 181.
16. Vilches, J.; Florencio, F.; Smith-Verdier, P.; Garcıa-
Blanco, S. Acta Cryst. 1981, B37, 201 For other examples on
5,5-disubstituted hydantoins X-ray analysis, see ref 17b and
references cited therein.
17. For review on hydantoin and thiohydantoin chemistry,
see: (a) Ware, E. Chem. Rev. 1950, 46, 403. (b) Lopez, A. C.;
Trigo, G. Adv. Heterocycl. Chem. 1985, 38, 177.
28. Ozawa, T.; Isoda, Y.; Watanabe, H.; Yuzuri, T.; Suezawa,
H.; Sakakibara, K.; Hirota, M. Magn. Reson. Chem. 1997, 35,
323.
29. Morie, T.; Kato, S.; Harada, H.; Fujiwara, I.; Watanabe,
K.; Matsumoto, J.-I. J. Chem. Soc. Perkin Trans 1 1994, 18,
2565.
30. Stables, J. P.; Kupferberg, H. J. In Molecular and Cel-
lular Targets for Antiepileptic Drugs; Avanzini, G., Tanga-
nelli, P., Avoli, M., Eds.; John Libbey: London, 1997; pp
191–198.
31. Levy, R. H.; Mattson, R.; Meldrum, B. Antiepileptic
Drugs, 4th ed; Raven: New York, 1995; Chapter 6.
32. Porter, R. J.; Cereghino, J. J.; Gladding, G. D.; Hessie,
B. J.; Kupferberg, H. J.; Scoville, B.; White, B. G. Cleveland
Clin. Q 1984, 51, 293.
33. Dunham, M. S.; Miya, T. A. J. Am. Pharm. Assoc. 1957,
46, 208.
34. Consistent with this notion, the MES ED50 value for ben-
zyl 2-acetamidopropionate was >100, <300 mg/kg in mice
(ip); Andurkar, S.; Kohn, H., unpublished data.
35. Paruszewski, R.; Rostafinska-Suchar, G.; Strupinska, M.;
Jaworski, P.; Winiecka, I.; Stables, J. P. Pharmazie 1996, 51,
212.
36. (a) Cortes, S. PhD Dissertation, University of Houston,
May, 1983. (b) Cortes, S.; Kohn, H. J. Org. Chem. 1983, 30,
3414.
37. (a) Jones, G. L.; Woodbury, D. M. Drug Dev. Res. 1982,
2, 233. (b) Poupaert, J. H.; Vandervorst, D.; Guiot, P.;
Moustafa, M. M. M.; Dumont, P. J. Med. Chem. 1984, 27, 76.
(c) Mehta, N. B.; Risinguer Diuguid, C. A. J. Med. Chem.
1981, 24, 465. (d) Henderson, J. D.; Dayton, P. G.; Israili,
Z. H.; Mandell, L. J. Med. Chem. 1981, 24, 843. (e) Sun, Z.-
Y.; Kwon, C.-H.; Wurpel, J. N. D. J. Med. Chem. 1994, 37,
2841.
38. (a) Hamill, O. P.; Marty, A.; Neher, E.; Sakmann, B.;
Sigworth, F. Pflugers Arch. 1981, 391, 85. (b) Hertz, E.; Yu,
A.C.H.; Hertz, L.; Juurlink, B.H.J.; Schousboe, A. In ADis-
section and Tissue Culture Manual of the Nervous System;
Shahar, A., Devillis, J., Vernadakis, A., Harber, B., Eds.; Alan
R. Liss: New York, 1990; pp 183–186.
39. Data generated by University of Utah, Anticonvulsant
Drug Development Program via contract throught the NIH,
NINDS, Anticonvulsant Screening Project, Rockville, MD,
USA.
18. von Braun, J. Ann 1931, 490, 100.
40. Lee, J. C.; Cho, Y. H.; Lee, H. K.; Cho, S. H. Synth.
Commun. 1995, 18, 2877.
41. Cox, C.; Lectka, T. J. Am. Chem. Soc. 1998, 120, 10660.
42. Finkbeiner, H. J. Org. Chem. 1965, 30, 3414.
43. Markwalder, J. A.; Pottorf, R. S.; Seitz, S. P. Synlett 1997,
521.
19. (a) Kushner, S.; Cassell, R. I.; Morton, J.; Williams, J. H.
J. Org. Chem. 1951, 16, 1283. (b) Brady, W. T.; Holifield,
B. M. Tetrahedron Lett. 1966, 5511.
20. (a) McManus, J. M.; Herbst, R. M. J. Org. Chem. 1959,
24, 1643. (b) Harvill, E. K.; Herbst, R. M.; Schreiner, E. C. J.
Org. Chem. 1952, 17, 1597.
44. Swinyard, E. A.; Woodhead, J. H.; White, H. S.; Franklin,